Loading clinical trials...
Loading clinical trials...
An Exploratory, Multicenter, Investigator-blinded, Active-controlled Study to Investigate the Efficacy of Topical Azelaic Acid (AzA)15% Gel Twice Daily or Metronidazole Topical Gel 1% Once Daily, Plus Anti-inflammatory Dose Doxycycline (40mg) Once Daily in Subjects With Moderate Papulopustular Rosacea
Conditions
Interventions
Azelaic acid (Finacea, BAY39-6251)
Metronidazole (Metrogel)
+1 more
Locations
17
United States
Birmingham, Alabama, United States
Denver, Colorado, United States
West Palm Beach, Florida, United States
Boston, Massachusetts, United States
Warren, Michigan, United States
Fridley, Minnesota, United States
Start Date
February 1, 2009
Primary Completion Date
April 1, 2009
Completion Date
July 1, 2009
Last Updated
March 31, 2020
NCT01872715
NCT01494467
NCT04608500
NCT02393937
NCT03263273
NCT01933464
Lead Sponsor
LEO Pharma
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions